¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"growth failure"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® growth hormone ÇÑ±Û ¼ºÀåÈ£¸£¸ó
¼³¸í   
  ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÁß Çϳª·Î¼­ ½Ã»óÇϺÎÀÇ ¼ºÀåÈ£¸£¸ó¹æÃâ È£¸£¸ó¿¡ ÀÇÇØ ºÐºñ°¡ ÀڱصǸ砼Ҹ¶Å佺Ÿƾ(somatostatin: ÀÌÀÚ¿¡¼­ ºÐºñµÇ¸ç, ¼ºÀåÈ£¸£¸ó¿¡ ¹Ý´ëµÇ´Â ÀÛ¿ëÀ» ÇÔ)¿¡ ÀÇÇØ ºÐºñ°¡ ¾ïÁ¦µÈ´Ù. ¼ºÀå È£¸£¸ó ¹æÃâ È£¸£¸óÀº µµÆÄ¹Î(dopamine)À¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¼ºÀå È£¸£¸óÀº ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŰ¸ç Æ¯È÷ °ñÀÇ ¼ºÀåÀ» ÀÚ±ØÇϴµ¥ ±× ÀÛ¿ëÀº Á÷Á¢ ¼¼Æ÷¿¡ ÀÛ¿ëÇϴ °ÍÀÌ ¾Æ´Ï¶ó °£°ú ±ÙÀ°¿¡ ÀÛ¿ëÇÏ¿© ±×°÷¿¡¼­ ¼Ò¸¶Åä¸ÞµòÀ» »ý¼ºÇϸç ÀÌ ¼Ò¸¶Åä¸ÞµòÀÌ ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŲ´Ù. ÇÑÆí ¼ºÀå È£¸£¸óÀº ¼ºÀå¿¡ ÇÊ¿äÇÑ ´Ü¹éÁú ÇÕ¼ºÀ» Ç×Áø½ÃŰ°í ¿¡³ÊÁö´Â Áö¹æÀ» ÀÌ¿ëÇÏ¿© ¾ò°ÔÇϹǷΠÁö¹æÀÌ¿ëÈ£¸£¸óÀ̶ó°íµµ ºÒ¸°´Ù. ¼ºÀå È£¸£¸óÀÌ °ú´Ù ºÐºñµÇ¸é °ÅÀÎÁõ, ¸»´Üºñ´ëÁõÀÌ À¯¹ßµÇ¸ç ¼ºÀå È£¸£¸óÀÌ °áÇ̵Ǹ頼ºÀåºÎÁøÀÌ ¿Â´Ù.
¿µ¹® growth factor ÇÑ±Û ¼ºÀåÀÎÀÚ
¼³¸í   
  ¼¼Æ÷ÀÇ ºÐÈ­ ¹× ¼ºÀå¿¡ °ü¿©Çϴ ´Ü¹éÁú. ¼ºÀåÀÎÀڴ Á¤»ó ¼¼Æ÷Áֱ⿡ ÇʼöÀûÀ̱⠶§¹®¿¡ µ¿¹°ÀÇ »ý¸í¿¡ Áß´ëÇÑ ¿ä¼Ò°¡ µÈ´Ù. ¹«¾ùº¸´Ùµµ ¼ºÀåÀÎÀڴ Å¾ÆÀÇ ¹ßÀ°À» Á¶Á¤Çϰí Á¶Á÷ÀÇ À¯Áö ¹× º¸¼ö¿¡ Áß´ëÇÑ ¿ªÇÒÀ» Çϸç, Ç÷±¸ÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. ¶ÇÇÑ ¾ÏÀÇ ÁøÇà°úÁ¤¿¡µµ °ü¿©ÇÑ´Ù.
¿µ¹® heart failure ÇÑ±Û ½ÉÀå±â´É»ó½Ç
¼³¸í   
  ¸öÀÇ Á¶Á÷À̳ª ±â°ü¿¡¼­ ´ë»ç¿¡ ÇÊ¿äÇÑ ¸¸Å­ ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾øÀ» Á¤µµ·Î ½ÉÀå±â´ÉÀÌ ÀúÇϵǾî Àִ »óÅÂÀÌ´Ù. ½ÉÀå±â´É»ó½ÇÀº ½É±ÙÀÌ ¼öÃàÇÒ ´É·ÂÀÌ ÀúÇϵǾúÀ» ¶§³ª ½ÉÀå¿¡ ½É¹ÚÃâÀ» Çϱâ À§ÇÑ ¾Ð·ÂÀÌ Á¤»óº¸´Ù Áõ°¡µÇ¾î Á¤»óÀÇ ½ÉÀåÀÇ ¼öÃàÀ¸·Î´Â ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾ø´Â °æ¿ì, ±×¸®°í ½ÉÀå±ÙÀ°, ½ÉÀå¿¡ °É¸®´Â ¾Ð·ÂÀº Á¤»óÀ̳ª ½ÉÀå¹Úµ¿ÀÇ À̻󿡠ÀÇÇØ¼­ Á¤»óÀûÀΠ¼öÃàÀÌ ºÒ°¡´ÉÇÒ °æ¿ì¿¡ »ý±ä´Ù.
¿µ¹® congestive heart failure ÇÑ±Û ¿ïÇ÷¼º½ÉÀå±â´É»ó½Ç
¼³¸í   
  ½ÉÀåÀÇ ¿ø·¡ ±â´É, Áï Ç÷¾×À» ¸»ÃʷΠº¸³»´Â ÆßÇÁ¿Í °°Àº ±â´ÉÀÌ °ÅÀÇ ¾ø¾îÁø »óŸ¦ ¸»ÇÑ´Ù. ÇǸ¦ º¸³»´Â ÆßÇÁÀÇ ¿ªÇÒÀÌ ¸ØÃß¾úÀ¸¹Ç·Î ½ÉÀåÀ¸·Î µé¾î¿À´Â ÇǴ ½ÉÀåÀ¸·Î µé¾î¿ÀÁö ¸øÇϰí Á¤¸Æ¼Ó¿¡¼­ Á¤Ã¼ÇϰԠµÈ´Ù. ±×¸®ÇÏ¿© Ç÷¾×ÀÇ ´ëºÎºÐÀÌ ¸»ÃÊÀÇ Á¤¸Æ¿¡ ¸Ó¹°°Ô µÇ¾î ¿©·¯ °¡Áö Áõ»óÀÌ ³ªÅ¸³­´Ù. Æ¯È÷ ÇãÆÄ¸¦ µ¹¾Æ Á½ɹæÀ¸·Î µé¾î°¡¾ßÇϴ Çǰ¡ ÆßÇÁ ±â´ÉÀÌ ¾ø¾îÁ®¼­ ¿Þ½É¹æ¿¡ ¸¹Àº Çǰ¡ Á¤Ã¼Çϰí À־ µé¾î°¡Áö ¸øÇؼ­ ÇãÆÄ¿¡ °íÀ̰ԠµÈ´Ù. ±×·¯¸é ÇãÆÄ¿¡ »ê¼Ò¿Í ÀÌ»êȭź¼Ò¸¦ ±³È¯Çϴ ±â´ÉÀÌ ¾ø¾îÁ®¼­ ¼ûÀ» ½¬Áö ¸øÇϴ °á°ú¸¦ ³½´Ù. Áï ¼ûÀÌ Â÷°í ¼û½¬±â Èûµç Áõ¼¼°¡ ³ªÅ¸³­´Ù. ¶Ç ¿Â¸öÀ» ¼øÈ¯ÇÑ ´ÙÀ½¿¡ ¿ì½É¹æÀ¸·Î µé¾î¿Í¾ßÇϴ Çǵµ ¿ì½É¹æÀ¸·Î µé¾î¿ÀÁö ¸øÇؼ­ ¸»ÃÊ¿¡ Á¤Ã¼ÇϹǷΠ¿Â¸öÀÌ º×°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth failure
    ¹ßÀ°ºÎÀü, ¼ºÀåºÎÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrial failure
    ½É¹æ±â´É»ó½Ç, ½É¹æºÎÀü
  • acute renal failure
    ±Þ¼ºÄáÆÏ±â´É»ó½Ç, ±Þ¼º½ÅºÎÀü
  • backward heart failure
    µÚÂʽÉÀå±â´É»ó½Ç, ÈÄÇâ½É(Àå)ºÎÀü
  • circulatory failure
    ¼øÈ¯±â´É»ó½Ç, ¼øÈ¯ºÎÀü
  • congestive heart failure
    ¿ïÇ÷½ÉÀå±â´É»ó½Ç, ¿ïÇ÷½ÉºÎÀü
  • cardiac failure
    ½ÉÀå±â´É»ó½Ç, ½É(Àå)ºÎÀü
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü
  • failure
    ±â´É»ó½Ç, ºÎÀü
  • failure to thrive
    ¼ºÀåÀå¾Ö
  • forward heart failure
    ¾ÕÂʽÉÀå±â´É»ó½Ç, ÀüÇâ½É(Àå)ºÎÀü
  • fulminant hepatic failure
    Àü°Ý°£±â´É»ó½Ç
  • hypodiastolic failure
    ÀúÈ®Àå±â½ÉÀå±â´É»ó½Ç, ÀúÈ®Àå±â½ÉºÎÀü
  • hypoxemic respiratory failure
    Àú»ê¼ÒÇ÷ÁõÈ£Èí±â´É»ó½Ç, Àú»ê¼ÒÇ÷ÁõÈ£ÈíºÎÀü
  • hypoxic heart failure
    Àú»ê¼Ò½ÉÀå±â´É»ó½Ç, Àú»ê¼Ò½É(Àå)ºÎÀü
  • heart failure
    ½ÉÀå±â´É»ó½Ç, ½ÉºÎÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • failure
    ±â´É»ó½Ç
  • acute renal failure
    ±Þ¼ºÄáÆÏ±â´É»ó½Ç, ±Þ¼º½ÅºÎÀü(Áõ)
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü(Áõ)
  • fulminant hepatic failure
    Àü°Ý°£±â´É»ó½Ç, Àü°Ý°£ºÎÀü
  • hemostatic failure
    ÁöÇ÷±â´É»ó½Ç, ÁöÇ÷ºÎÀü
  • ovarian failure
    ³­¼Ò±â´É»ó½Ç, ³­¼ÒºÎÀü
  • respiratory failure
    È£Èí±â´É»ó½Ç, È£ÈíºÎÀü
  • growth factor
    ¼ºÀåÀÎÀÚ
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • growth
    ¼ºÀå, Áõ½Ä
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁö¿¬
  • growth spurt
    ¼ºÀå±ÞÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrial failure
    ½É¹æ±â´É»ó½Ç
  • backward failure theory
    ÈĹæÀå¾Ö¼³
  • backward heart failure
    µÚÂʽÉÀå±â´É»ó½Ç, ÈÄÇâ½ÉÀåºÎÀü
  • cardiac failure
    (¢¡heart failure) ½ÉÀå±â´É»ó½Ç, ½ÉÀåºÎÀü
  • circulatory failure
    ¼øÈ¯±â´É»ó½Ç, ¼øÈ¯ºÎÀü
  • congestive heart failure
    ¿ïÇ÷½ÉÀå±â´É»ó½Ç, ¿ïÇ÷½ÉºÎÀüÁõ
  • failure
    ±â´É»ó½Ç
  • forward heart failure
    ¾ÕÂʽÉÀå±â´É»ó½Ç, Àü¹æ½ÉÀåºÎÀü
  • heart failure
    ½ÉÀå±â´É»ó½Ç, ½ÉÀåºÎÀü
  • high-output heart failure
    °í¹ÚÃâ½ÉÀå±â´É»ó½Ç, °í¹ÚÃâ½ÉÀåºÎÀü
  • hypodiastolic failure
    ÀúÈ®Àå±â½ÉÀå±â´É»ó½Ç, ÀúÈ®Àå±â½ÉºÎÀü
  • hypoxemic respiratory failure
    Àú»ê¼ÒÇ÷ÁõÈ£Èí±â´É»ó½Ç, Àú»ê¼ÒÇ÷ÁõÈ£ÈíºÎÀü
  • hypoxic heart failure
    Àú»ê¼Ò½ÉÀå±â´É»ó½Ç, Àú»ê¼Ò½ÉÀåºÎÀü
  • intractable heart failure
    ³­Ä¡½ÉÀå±â´É»ó½Ç, ³­Ä¡½ÉÀåºÎÀü
  • left sided heart failure
    (¢¡left ventricular failure) ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth failure
    ¼ºÀåºÎÀü(à÷íþÝÕîï).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • Congestive heart failure
    ¿ïÇ÷¼º(ê¦úìàõ)½ÉºÎÀü(ãýÜôîï)
  • Heart failure
    ½ÉºÎÀü(ãýÜôîï)
  • RFI=>renal failure index
    ½ÅºÎÀüÁö¼ö
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü(¡­ãýÝÕîï).
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
  • fusion failure
    À¶ÇÕºÎÀü
  • heart failure
    ½ÉºÎÀü(ãýÝÕîï).
  • heart failure cell
    ½ÉºÎÀü¼¼Æ÷(¡­á¬øà)
  • hepatic failure
    °£ºÎÀü(ÊÜÝÕîï).
  • hepatic failure
    °£ºÎÀü(ÊÜÜôîï)
  • hepatic failure
    °£ºÎÀü(°£ºÒÀü).
  • high output failure
    °í¹ÚÃ⼺ ½ÉºÎÀü.
  • high output heart failure
    °í¹ÚÃ⼺ ½ÉºÎÀü(ÍÔÚÐõóàõãýÝÕîï).
  • hypodiastolic failure
    ÀúÈ®Àå±â¼º ½ÉºÎÀü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth failure
    ¼ºÀåºÎÀü(à÷íþÝÕîï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiac failure =heart failure
    ½ÉºÎÀü(Áõ)(ãýÜôîï[ñø]).
  • cardiac failure =heart failure
    ½ÉºÎÀü(Áõ)(ãýÝÕîïñø).
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü(¡­ãýÝÕîï).
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
  • atrial failure
    ½É¹æºÎÀü(ãýÛ®ÝÕîï).
  • backward failure (theory)
    ÈĹæÀå¾Ö(¼³) (¡­î¡äôæò).
  • backward failure (theory)
    ÈĹæÀå¾Ö(¼³) (ý­Û°î¡äô(àâ))
  • backward heart failure
    ÈÄÇâ (¹æ)½ÉºÎÀü (¡­ãýÝÕîï).
  • backward heart failure
    ÈĹæ½ÉºÎÀü (ý­Û°ãýÝÕîï).
  • bone marrow failure
    °ñ¼ö±â´ÉºÎÁø.
  • cardiac failure
    ½ÉºÎÀü
  • cardiac failure
    ½ÉºÎÀü(ãýÜôîï)
  • cardiac insufficiency =c. failure
    ½ÉºÎÀü(Áõ)(ãýÜôîï[ñø])
  • cardiac insufficiency =c. failure
    ¼øÈ¯½ÉºÎÀü(Áõ)(ãýÝÕîïñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Appositional growth
    µ¡ºÙÀ̼ºÀå
    [¿¾ ¿ë¾î] ÷°¡¼ºÀå
  • Abnormal growth
    ºñÁ¤»ó¼ºÀå
    [¿¾ ¿ë¾î] ºñÁ¤»ó¼ºÀå
  • Interstitial growth
    »çÀÌÁú¼ºÀå
    [¿¾ ¿ë¾î] °£Áú¼ºÀå
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Growth defect
    ¼ºÀå°áÇÔ
    [¿¾ ¿ë¾î] ¼ºÀå°áÇÔ
  • Growth cone
    ¼ºÀå¿ø»Ô
    [¿¾ ¿ë¾î] ¼ºÀå¿øÃß
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    °íÁ¤ºñÀÇÁ¸¼º¼ºÀå(ͳïÒÞªëîðíàõà÷íþ)
  • asynchronous growth
    ºñµ¿½Ã¼º ¼ºÀå (ÞªÔÒãÁàõà÷íþ)
  • balanced growth
    ±ÕÇü¼ºÀå(гû¬à÷íþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • comb growth test
    °è°ü ¼ºÀå½ÃÇè(ͮήà÷íþãËúÐ)
  • confluent growth
    Àü¸é¼ºÀå(îïØüà÷íþ)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • epidermal growth factor
    Ç¥ÇǼºÀåÀÎÀÚ (øúù«à÷íþì×í­)
  • epithelial growth factor
    »óÇǼºÀåÀÎÀÚ (ß¾ù«à÷íþì×í­)
  • exponential growth
    Áö¼ö ¼ºÀå (ò¦â¦à÷íþ)
  • exponential growth rate constant
    Áö¼ö ¼ºÀå¼Óµµ »ó¼ö (ò¦â¦à÷íþáÜÓøßÈâ¦)
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • growth curve
    ¼ºÀå°î¼± (à÷íþÍØàÊ)
  • growth factor
    ¼ºÀåÀÎÀÚ (à÷íþì×í­)
  • growth hormone
    ¼ºÀå(à÷íþ)È£¸£¸ó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiac failure
    ½ÉºÎÀüÁõ
  • failure
    ºÎÀüÁõ, ÆÄ¼Õ
  • heart failure
    ½ÉºÎÀü
  • hepatic failure
    °£ºÎÀü
  • high output heart failure
    °í¹ÚÃ⼺½ÉºÎÀü
  • renal failure
    ½ÅºÎÀü
  • respiratory failure
    È£ÈíºÎÀü
  • growth
    ¼ºÀå
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • growth arrest line
    ¼ºÀåÁö¿¬¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth line
    ¼ºÀå¼±
  • growth retardation
    ¼ºÀåÁö¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
POF pattern of failure; position of function; premature ovarian failure; primary ovarian failure; pyruva...
GF gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
TGF T-cell growth factor; transforming growth factor; tuboglomerular feedback; tumor growth factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HB-EGF Heparin binding epidermal growth factor-like growth factor
HB-EGF Heparin-binding epidermal growth factor (EGF)-like growth factor
GH-IGF-I growth hormone-insulin-like growth factor I
ARF Acute Renal Failure
ARF Acute Respiratory Failure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü
    ±Þ¼º ¼øÈ¯ ºÎÀüÀÇ ÇϳªÀÌ°í ¿øÀÎÀÌ ½ÉÀå¿¡ ÀÖÀ» ¶§¸¦ ¸»ÇÑ´Ù. ±Þ¼º Á½ɺÎÀüÀº °íÇ÷¾Ð, ´ëµ¿¸ÆÆÇ ¹× ½Â¸ðÆÇ¸·Áõ, ½É±Ù¿°, Ư¹ß¼º ½É±ÙÁõ µî¿¡ À־ Á½ɽǿ¡ °©Àڱ⠻ý±ä ¼öÃà ºÎÀüÀ¸·Î ÀÎÇØ¼­ »ý±â´Â °ÍÀ̰í, Æó ¿ïÇ÷À» °¡Á®¿Í ¹ßÀÛ¼º È£Èí°ï¶õÀÌ »ý±ä´Ù. ±Þ¼º ¿ì½ÉºÎÀüÀº ±Þ¼º Æó»öÀü, ½É±Ù¿° µî¿¡ ÀÇÇØ ¿ì½ÉÀÇ ±Þ¼º ¼öÃà ºÎÀüÀÌ »ý°åÀ» ¶§¿¡ ÀÏÀ¸Å°°í ¿ì½ÉÀ¸·ÎÀÇ È¯·ù °¨¼Ò·Î ÀÎÇØ¼­ Ç÷¾ÐÀúÇÏ, ¼îÅ©°¡ »ý±ä´Ù. È£Èí°ï¶õ, ºóÈ£ÈíÀ» ³ªÅ¸³»±âµµ ÇÑ´Ù.
  • backward heart failure
    ÈÄÇ⠽ɺÎÀü
  • bone marrow failure
    °ñ¼ö ±â´ÉºÎÁø
  • cardiac failure
    ½ÉºÎÀü, ½ÉºÎÀüÁõ
    µ¿ÀǾî=heart failure. ÃæºÐÇÑ Á¤¸Æ Ãæ¸¸¾ÐÀÌ Àִµ¥µµ »ýüÀÇ ¼ö¿ä¿¡ ´ëÇØ¼­ ÀûÀýÇÑ ¼øÈ¯À» À¯ÁöÇÒ ¼ö ¾ø°Ô µÈ »óÅÂ.
  • circulatory failure
    ¼øÈ¯ ºÎÀü
  • cohesional failure
    ÀÀÁý ÆÄ±«
    Á¢Âø·ÂÀÌ ÃæºÐÈ÷ Å©°í, Á¢ÂøÁ¦ Ãþ ¶Ç´Â ÇÇÂøÃ¼ ³»ºÎ¿¡ »ý±ä ÆÄ±«.
  • failure
    ºÎÀü, ºÎÀüÁõ, ÆÄ¼Õ
    ±â´ÉÀÇ ¼öÇàÀÌ ºÒ°¡´ÉÇÑ °Í.
  • fatigue failure
    ÇÇ·Î ÆÄ¼Õ
  • heart failure
    ½ÉºÎÀü
    ½É ¹ÚÃâ·®ÀÇ Àå¾Ö ¶Ç´Â Á¤¸Æ¾ÐÀÇ »ó½ÂÀ¸·Î ¹ß»ýÇϴ ƯÀ¯ÇÑ ÀÚ°¢Àû ¹× Ÿ°¢Àû Áõ»óÀ» Ư¡À¸·Î ÇÏ´Â ÀÓ»óÀû ÁõÈıº. ½É½Ç È®À强ÀÇ ¾Ð·Â Áõ´ë¿Í Àü½ÅÀÇ Çʿ䷮¿¡ ºÎÁ·ÇÑ ½É ¹ÚÃâ·®À» ¼ö¹ÝÇÏ´Â ½É±Ù ºÎÀü¿¡ ´ëÇÏ¿© °¡Àå ºó¹øÇÏ°Ô »ç¿ëµÇ´Â ¸»ÀÌ´Ù. Àü½Å Á¤¸Æ ¶Ç´Â Æó Á¤¸ÆÀÇ ¾î´À ÂÊÀÇ È®ÀåÀÌ ´õ¿í ½ÉÇѰ¡¿¡ µû¶ó ¿ìÃø ½ÉºÎÀü ȤÀº ÁÂÃø ½ÉºÎÀüÀ¸·Î ¼¼ºÐµÉ ¶§°¡ ¸¹´Ù.
  • hepatic failure
    °£ ±â´É ºÎÀü, °£ ºÎÀüÁõ, °£ ºÎÀü
    °£ÀÌ Á¦ ±â´ÉÀ» ¼öÇàÇÏÁö ¸øÇÏ´Â º´Àû »óÅÂ.
  • left atrial failure
    ÁÂ¹æ ºÎÀü, ÁÂ½É¹æ ºÎÀü
  • left heart failure
    ÁÂ½É ºÎÀü, ÁÂ½É½Ç ºÎÀü
  • left sided heart failure
    ÁÂ½É ºÎÀü
  • left ventricular failure
    Á ½É½Ç ºÎÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute kidney failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
acute respiratory failure Loss of pulmonary function either acute or chronic that results in hypoxaemia or hypercarbia.
(05 Mar 2000)
backward heart failure A concept (formerly considered mutually exclusive of forward heart failure) that maintains that the phenomena of congestive heart failure result from passive engorgement of the veins caused by a "backward" rise in pressure proximal to the failing cardiac chambers.
Compare: forward heart failure.
(05 Mar 2000)
cardiac failure A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
pacemaker failure Failure of an artificial pacemaker to generate or deliver effective stimuli to the myocardium.
(05 Mar 2000)
renal failure Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. If renal function declines to a low enough level (end-stage renal disease) kidney dialysis may be necessary. A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
respiratory failure A clinical syndrome that is defined either by the inability to rid the body of C02 or establish an adequate blood oxygen level (PAO2).
See: arterial blood gas.
(27 Sep 1997)
right ventricular failure An weakening of the right ventricle that results in the back up of blood in the venous system, liver, gastrointestinal tract and extremities. The causes of this condition include left-sided congestive heart failure, emphysema, valvular heart disease, cardiomyopathy, anaemia, hyperthyroidism, cor pulmonale and congenital heart disease. Risk factors include diabetes, alcoholism, obesity and smoking.
Symptoms include swelling of the feet and ankles, nocturia, increased distention of neck veins, fatigue, weakness and fainting, Ascites, arrhythmias and pleural effusions are complications of right ventricular failure.
(27 Sep 1997)
chronic kidney failure Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. If renal function declines to a low enough level (end-stage renal disease) kidney dialysis may be necessary. A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
chronic renal failure <nephrology> Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. If renal function declines to a low enough level (end-stage renal disease) kidney dialysis may be necessary. A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
multiple organ failure A progressive condition usually characterised by combined failure of the lungs, liver, kidney, and clotting mechanisms, usually postinjury or postoperative.
(12 Dec 1998)
congestive heart failure A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
coronary failure Acute coronary insufficiency.
(05 Mar 2000)
power failure Synonym: pump failure.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • failure
    ½ÇÆÐ,°á
  • failure
    ½Ç¼ö;½ÇÆÐ;½ÇÆÐÀÚ;À߸øµÈ °Í;½ÇÆÐÇÑ °èȹ;Ÿ¸;ºÒÀÌÇà;ºÎÁ·;ºÒÃæºÐ;¾øÀ½;°¨Åð;¼èÅð;ÁöºÒÁ¤Áö;ÆÄ»ê;°íÀå;Á¤Áö;ÆÄ±«;ÆÄ¼Õ;³«Á¦
  • heart failure
    ½ÉÀ帶ºñ;½ÉÀå¹ßÀÛ
  • power failure
    Á¤Àü;Àü±â°íÀå
  • growth
    ¼ºÀå,¹ß´Þ,Áõ°¡
  • economic growth rate
    °æÁ¦ ¼ºÀå·ü 9
  • growth
    ¼ºÀå;»ýÀå;¹ßÀ°;¹ß´Þ;Áõ´ë;Àç¹è;»ýÀå(¹ß»ý)¹°;»ê¹°
  • growth center
    (sensitivity trainingµîÀ»ÇÏ´Â)´É·Â °³¹ß ¼¾ÅÍ)
  • growth hormone
    ¼ºÀå È£¸£¸ó 
  • growth industry
    ¼ºÀå »ê¾÷
  • growth stock
    ¼ºÀåÁÖ
  • human growth hormone
    Àΰ£¼ºÀå È£¸£¸ó(ÀÎüÀÇ ¼ºÀåÀ» Áö¹èÇÏ´Â ³úÇϼöü Á¾ÇÕ È£¸£¸ó)
  • mushroom growth
    ±Þ°ÝÇÑ ¼ºÀå
  • negative growth
    (°æÁ¦ÀÇ)¸¶À̳ʽº ¼ºÀå
  • nerve growth factor
    (»ý¸®)½Å°æ ¼ºÀåÀÎÀÚ(Áö°¢(±³°¨)½Å°æ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ´Ü¹éÁú)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á